Cerenome (CNSY) Share-based Compensation Growth (3y) (2013 - 2026)
Powered by 
Analysis
Cerenome (CNSY) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 12.91% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 6.35% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 58.16% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 17.49% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 9.95% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 4.55% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 30.98% |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | 75.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.92% |
| Mar 31, 2026 | 37.18% |
| Dec 31, 2025 | 76.35% |
| Sep 30, 2025 | 112.49% |
| Jun 30, 2025 | 0.83% |
| Mar 31, 2025 | 2.72% |
| Dec 31, 2024 | 90.64% |
| Sep 30, 2024 | -18.90% |
| Jun 30, 2024 | -25.60% |
| Mar 31, 2024 | -24.03% |
| Dec 31, 2023 | 12.89% |
| Sep 30, 2023 | -89.94% |
| Jun 30, 2023 | -90.57% |
| Mar 31, 2023 | 184.21% |
| Dec 31, 2022 | 83.61% |
| Sep 30, 2022 | 243.46% |
| Jun 30, 2022 | 249.95% |
| Mar 31, 2022 | 188.03% |
| Dec 31, 2021 | 82.05% |
| Sep 30, 2021 | 159.34% |